Related Experiment Video

Updated: May 6, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

9.2K

Immunotherapy for lung cancer: ongoing clinical trials

Sarah Declerck1, Johan Vansteenkiste

  • 1Respiratory Oncology Unit (Department of Pulmonology) & Leuven Lung Cancer Group, University Hospital KU Leuven, Leuven, Belgium.

Future Oncology (London, England)
|October 23, 2013
PubMed

Insights

Novel immunotherapies show promise for lung cancer. Cancer vaccines and immune-modulating antibodies are being tested in clinical trials for non-small cell lung cancer (NSCLC).

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Past decades of lung cancer immunotherapy have seen limited success.
  • Recent advances in understanding tumor immunology have led to novel immunotherapeutic agents.
  • Two main approaches have emerged: antigen-specific and non-antigen-specific immunotherapy.

Purpose of the Study:

  • To review novel immunotherapeutic agents for lung cancer.
  • To discuss antigen-specific immunotherapy (cancer vaccination) and non-antigen-specific immunotherapy (cancer immunomodulation).
  • To highlight recent clinical trial outcomes and future directions.

Main Methods:

  • Review of antigen-specific vaccines (MAGE-A3, L-BLP25, belagenpumatucel-L, TG4010) in various stages of non-small cell lung cancer (NSCLC).
  • Review of non-antigen-specific immunotherapies, including monoclonal antibodies targeting CTLA-4 and PD-1/PD-L1 pathways.
  • Analysis of recent Phase II trial data regarding efficacy and tolerability.

Main Results:

  • Phase II trials of novel immunotherapies in lung cancer have demonstrated promising efficacy and tolerability.
  • Several agents, including cancer vaccines and immune checkpoint inhibitors, are advancing to Phase III trials.
  • Ongoing and recently completed Phase III trials are expected to yield significant results.

Conclusions:

  • Immunotherapy has become a promising strategy for treating lung cancer.
  • Both cancer vaccination and immune modulation offer potential therapeutic benefits.
  • Further clinical evaluation in Phase III trials is crucial for establishing the role of these novel treatments in lung cancer care.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

11.4K
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.7K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Cancer Therapies02:49

Cancer Therapies

2.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K